Evidence map›Paper›PMID 40076888›Full record

ArticleInternational journal of molecular sciences2025

Improving Atorvastatin Release from Polyelectrolyte Complex-Based Hydrogels Using Freeze-Drying: Formulation and Pharmaceutical Assessment of a Novel Delivery System for Oral Candidiasis Treatment.

Joanna Potaś-Stobiecka, Radosław Aleksander Wach, Bożena Rokita, Weronika Kaja Simonik, Magdalena Wróblewska, Karolina Borkowska, Silje Mork, Nataša Škalko-Basnet, Katarzyna Winnicka

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joanna Potaś-StobieckaDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Medical University of Białystok, Mickiewicza 2C, 15-222 Białystok, Poland.ORCID 0000-0001-9233-1330
Radosław Aleksander WachInstitute of Applied Radiation Chemistry, Faculty of Chemistry, Łódź University of Technology, Wróblewskiego 15, 93-590 Łódź, Poland.ORCID 0000-0001-7311-4525
Bożena RokitaInstitute of Applied Radiation Chemistry, Faculty of Chemistry, Łódź University of Technology, Wróblewskiego 15, 93-590 Łódź, Poland.
Weronika Kaja SimonikStudent Scientific Group, Department of Pharmaceutical Technology, Medical University of Białystok, Mickiewicza 2c, 15-222 Białystok, Poland.
Magdalena WróblewskaDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Medical University of Białystok, Mickiewicza 2C, 15-222 Białystok, Poland.ORCID 0000-0002-5782-679X
Karolina BorkowskaStudent Scientific Group, Department of Pharmaceutical Technology, Medical University of Białystok, Mickiewicza 2c, 15-222 Białystok, Poland.
Silje MorkDrug Transport and Delivery Research Group, Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Universitetsvegen 57, 9037 Tromsø, Norway.
Nataša Škalko-BasnetDrug Transport and Delivery Research Group, Department of Pharmacy, Faculty of Health Sciences, UiT The Arctic University of Norway, Universitetsvegen 57, 9037 Tromsø, Norway.ORCID 0000-0002-4301-2840
Katarzyna WinnickaDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Medical University of Białystok, Mickiewicza 2C, 15-222 Białystok, Poland.ORCID 0000-0002-1013-610X

Funding

Medical University of Białystok B.SUB.24.350
6 · The paper itself

Abstract

Atorvastatin calcium, an antifungal agent, has the potential to be repositioned/repurposed to combat the increasing antimicrobial resistance. However, one of the most crucial issues in developing atorvastatin calcium-loaded products with a topical antifungal effect is achieving the optimal release and dissolution rates of this statin to produce the desired therapeutic effect. In this paper, we report on the development and pharmaceutical assessment of hydrogels composed of low-molecular-weight chitosan, tragacanth, and xanthan gum/pectin/κ-carrageenan as potential drug carriers for atorvastatin calcium for buccal delivery. Multidirectional analysis of the carriers with regard to their drug-release profiles and mucoadhesive, antimicrobial, and cytotoxic properties was accompanied by an evaluation of the freeze-drying process used to improve the hydrogels' applicability. Using differential scanning calorimetry, Fourier transform infrared spectroscopy, and scanning electron microscopy techniques, the role of lyophilization in enhancing atorvastatin calcium delivery from polyelectrolyte complex-based matrices via drug amorphization was demonstrated. The freeze-dried hydrogels had significantly improved release and dissolution rates for the amorphic statin. Therefore, there is great potential for the use of lyophilization in the design of polyelectrolyte complex-based semi-solids in usable dosage forms for numerous crystalline and poorly water-soluble active substances.

Indexed as

Antifungal AgentsAtorvastatinDrug Delivery SystemsHydrogelsPolyelectrolytesDrug CarriersDrug LiberationFreeze DryingHumansAntifungal AgentsAtorvastatinDrug CarriersHydrogelsPolyelectrolytesatorvastatin calciumchitosanfreeze-dryingoral candidiasispectinpolyelectrolyte complexpolysaccharide hydrogeltragacanthxanthan gumκ-carrageenan

Identifiers

PMID40076888
PMCPMC11900555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.